• 1
    Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS & Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc 289, 7679.
  • 2
    Zimmet P, Alberti KG & Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414, 782787.
  • 3
    Pittas AG, Joseph NA & Greenberg AS (2004) Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89, 447452.
  • 4
    Hotamisligil GS, Murray DL, Choy LN & Spiegelman BM (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91, 48544858.
  • 5
    Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH & Bryer-Ash M (1998) An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 139, 49284935.
  • 6
    Liu LS, Spelleken M, Rohrig K, Hauner H & Eckel J (1998) Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes 47, 515522.
  • 7
    Boden G & Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3), 1423.
  • 8
    Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K et al. (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83, 859862.
  • 9
    Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 8791.
  • 10
    Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB & Flier JS (1995) Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44, 12661273.
  • 11
    Hotamisligil GS, Arner P, Caro JF, Atkinson RL & Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 24092415.
  • 12
    Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R & Simsolo RB (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95, 21112119.
  • 13
    Granner D, Andreone T, Sasaki K & Beale E (1983) Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature 305, 549551.
  • 14
    Spiegelman BM & Heinrich R (2004) Biological control through regulated transcriptional coactivators. Cell 119, 157167.
  • 15
    Saltiel AR & Kahn CR (2001) Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414, 799806.
  • 16
    Kaestner KH, Hiemisch H, Luckow B & Schutz G (1994) The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics 20, 377385.
  • 17
    Wolfrum C, Besser D, Luca E & Stoffel M (2003) Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci USA 100, 1162411629.
  • 18
    Brennan RG (1993) The winged-helix DNA-binding motif: another helix-turn-helix takeoff. Cell 74, 773776.
  • 19
    Gerrish K, Gannon M, Shih D, Henderson E, Stoffel M, Wright CV & Stein R (2000) Pancreatic beta cell-specific transcription of the pdx-1 gene. The role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. J Biol Chem 275, 34853492.
  • 20
    O’Brien RM, Noisin EL, Suwanichkul A, Yamasaki T, Lucas PC, Wang JC, Powell DR & Granner DK (1995) Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 15, 17471758.
  • 21
    Shih DQ, Navas MA, Kuwajima S, Duncan SA & Stoffel M (1999) Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci USA 96, 1015210157.
  • 22
    Wang JC, Stafford JM, Scott DK, Sutherland C & Granner DK (2000) The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. J Biol Chem 275, 1471714721.
  • 23
    Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J & Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857868.
  • 24
    Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R et al. (2006) Foxo1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281, 1010510117.
  • 25
    Nakae J, Kitamura T, Silver DL & Accili D (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108, 13591367.
  • 26
    Barthel A, Schmoll D, Kruger KD, Bahrenberg G, Walther R, Roth RA & Joost HG (2001) Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun 285, 897902.
  • 27
    Mavri-Damelin D, Eaton S, Damelin LH, Rees M, Hodgson HJ & Selden C (2007) Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. Int J Biochem Cell Biol 39, 555564.
  • 28
    Javitt BN (1990) HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J 4, 161168.
  • 29
    Gupta D, Varma S & Khandelwal RL (2007) Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB. J Cell Biochem 100, 593607.
  • 30
    Gupta D & Khandelwal RL (2004) Modulation of insulin effects on phosphorylation of protein kinase B and glycogen synthesis by tumor necrosis factor α in HepG2 cells. Biochem Biophys Acta 1671, 5158.
  • 31
    Zhang L, Rubins NE, Ahima RS, Greenbaum LE & Kaestner KH (2005) Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2, 141148.
  • 32
    Alikhani M, Alikhani Z & Graves DT (2005) Foxo1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem 280, 1209612102.
  • 33
    Ito Y, Daitoku H & Fukamizu A (2009) Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun 9, 290295.
  • 34
    Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A & White MF (2001) Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107, 181189.
  • 35
    de Alavaro C, Teruel T, Hernandez R & Lorenzo M (2004) Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 279, 1707017078.
  • 36
    Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A & Gerich J (1998) Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102, 619624.
  • 37
    Roden M, Petersen KF & Shulman GI (2001) Nuclear magnetic resonance studies of hepatic glucose metabolism in humans. Recent Prog Horm Res 56, 219237.
  • 38
    Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C & Rizza RA (1998) Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47, 17351747.
  • 39
    Clore JN, Helm ST & Blackard WG (1995) Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest 96, 19671972.
  • 40
    Niswender KD, Shiota M, Postic C, Cherrington AD & Magnuson MA (1997) Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272, 2257022575.
  • 41
    Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS & Friedman JE (2002) Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277, 2330123307.
  • 42
    Hughes DE, Stolz DB, Yu S, Tan Y, Reddy JK, Watkins SC, Diehl AM & Costa RH (2003) Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage. Hepatology 37, 14141424.
  • 43
    Chakravarty K, Wu SY, Chiang CM, Samols D & Hanson RW (2004) SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver. J Biol Chem 279, 1538515395.
  • 44
    Kaestner KH, Katz J, Liu Y, Drucker DJ & Schutz G (1999) Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev 13, 495504.
  • 45
    Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, Watkins SC, Franks RR, Unterman TG & Costa RH (2000) Elevated levels of hepatocyte nuclear factor 3βS in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20, 82648282.
  • 46
    Sund NJ, Ang SL, Sackett SD, Shen W, Daigle N, Magnuson MA & Kaestner KH (2000) Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol Cell Biol 20, 51755183.
  • 47
    Vallet V, Antoine B, Chafey P, Vandewalle A & Kahn A (1995) Overproduction of a truncated hepatocyte nuclear factor 3 protein inhibits expression of liver-specific genes in hepatoma cells. Mol Cell Biol 15, 54535460.
  • 48
    Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD & Edlund H (2005) The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 1, 245258.
  • 49
    Wang JC, Stromstedt PE, O’Brien RM & Granner DK (1996) Hepatic nuclear factor 3 is an accessory factor required for the stimulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Mol Endocrinol 10, 794800.
  • 50
    Wang JC, Stromstedt PE, Sugiyama T & Granner DK (1999) The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 beta (hepatic nuclear factor-3 beta) and HNF4 and the necessity of proper alignment of their cognate binding sites. Mol Endocrinol 13, 604618.
  • 51
    Hall RK, Wang XL, George L, Koch SR & Granner DK (2007) Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect. Mol Endocrinol 21, 550563.
  • 52
    Hill MR & McCallum RE (1992) Identification of tumor necrosis factor α as a transcriptional regulator of phosphoenolpyruvate carboxykinase gene following endotoxin treatment in mice. Infect Immun 60, 40404050.
  • 53
    Chang CK, Gatan M & Schumer W (1996) Efficacy of anti-tumor necrosis factor polyclonal antibody on phosphoenolpyruvate carboxykinase expression in septic and endotoxemic rats. Shock 6, 5760.
  • 54
    Yan J, Gao Z, Yu G, He Q, Weng J & Ye J (2007) Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha. Mol Endocrinol 21, 16301641.
  • 55
    Valera A, Pujol A, Pelegrin M & Bosch F (1994) Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91, 91519154.
  • 56
    Franckhauser S, Munoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B & Bosch F (2002) Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 51, 624630.
  • 57
    Franckhauser S, Munoz S, Elias I, Ferre T & Bosch F (2006) Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity. Diabetes 55, 273280.
  • 58
    Ling PR, Bistrian BR, Mendez B & Istfan NW (1994) Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. Metabolism 43, 279284.
  • 59
    Lang CH, Dobrescu C & Bagby GJ (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130, 4352.
  • 60
    Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J & Karin M (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11, 191198.
  • 61
    Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J & Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11, 183190.
  • 62
    Bae EJ, Yang YM, Kim JW & Kim SG (2007) Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway. Hepatology 46, 730739.
  • 63
    Choi JH, Park MJ, Kim KW, Choi YH, Park SH, An WG, Yang US & Cheong J (2005) Molecular mechanism of hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation. FEBS Lett 579, 27952801.
  • 64
    Lam NT, Lewis JT, Cheung AT, Luk CT, Tse J, Wang J, Bryer-Ash M, Kolls JK & Kieffer TJ (2004) Leptin increases hepatic insulin sensitivity and protein tyrosine phosphatase 1B expression. Mol Endocrinol 18, 13331345.
  • 65
    Senn JJ, Klover PJ, Nowak IA & Mooney RA (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 33913399.
  • 66
    Buser AC, Gass-Handel EK, Wyszomierski SL, Doppler W, Leonhardt SA, Schaack J, Rosen JM, Watkin H, Anderson SM & Edwards DP (2007) Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol 21, 106125.
  • 67
    Gabbay A, Sutherland C, Gnudi L, Kahn BB, O’Brien RM, Granner DK & Flier JS (1996) Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 271, 18901897.